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I am pleased and honored to accept
the position of Editor in Chief of Molecu-
lar Medicine, published by The Feinstein
Institute for Medical Research.
Molecular Medicine reflects The Fein-
stein Institute for Medical Research’s
continuous commitment to provide an
interface between basic science and
transforming clinical practice. I have
worked at this interface for many years,
guiding student and postdoctoral fellows
interested in translating biomedical re-
search into improved clinical practice. I
am very excited to be involved with a
journal that values the work done in this
scientific space.
Molecular Medicine is more than a sci-
entific journal. Over the past several
years, we have established and granted
the Ross Prize in Molecular Medicine
and the Anthony Cerami Award in
Translational Medicine. The Ross Prize
recognizes innovative, paradigm-shifting
research that is worthy of significant and
broad attention in the field of molecular
medicine. Additionally, by offering the
stories behind pioneering advances, the
Cerami Award monographs provide
sources of inspiration and insight to sub-
sequent generations.
In line with the mission of the journal
and publisher, we sponsor and dissemi-
nate content prepared for scientific meet-
ings such as the Merinoff World Con-
gress and the Merinoff Symposia.
My vision for the next phase of Molec-
ular Medicine is to continue providing a
journal that is user-friendly and respon-
sive to contributors. We look forward to
keeping our roster of contributing au-
thors who make the journal lively and
significant. Going forward, we plan on
expanding the topics covered by the
journal as well as developing special col-
lections around disease topics. For exam-
ple, this year, we celebrate the 20th an-
niversary of the journal and are planning
an exciting retrospective for the occasion.
I would like to thank Drs. Cerami and
Tracey for their stewardship of the jour-
nal over the past eight years, and I look
forward to their continued support as
Editors Emeriti.
In closing, I look forward to taking on
this new role, and I welcome suggestions
and feedback from you, our readers and
authors, that may improve your user 
experience.
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